Discovery and Optimization of Novel hDHODH Inhibitors for the Treatment of Inflammatory Bowel Disease

Author:

Zhou Xia12,Gou Kun1,Xu Jing1,Jian Lunan1,Luo Yuan1,Li Chungen1,Guan Xinqi1,Qiu Jiahao1,Zou Jiao1,Zhang Yu3,Zhong Xi4,Zeng Ting4,Zhou Yue1,Xiao Yuzhou1,Yang Xinyu4,Chen Weijie4,Gao Ping1,Liu Chunqi1,Zhou Yang1,Tao Lei1,Liu Xingchen4,Cen Xiaobo5ORCID,Chen Qiang1,Sun Qingxiang16ORCID,Luo Youfu1ORCID,Zhao Yinglan14ORCID

Affiliation:

1. Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China

2. Green Pharmaceutical Technology Key Laboratory of Luzhou, Central Nervous System Drug Key Laboratory of Sichuan Province, Department of Medicinal Chemistry, School of Pharmacy, Southwest Medical University, Luzhou 646000, China

3. School of Medicine, Tibet University, Lhasa 850000, China

4. West China School of Pharmacy, Sichuan University, Chengdu 610041, China

5. National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China

6. Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China

Funder

West China Hospital, Sichuan University

Natural Science Foundation of Sichuan Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3